Sanofi swaps executives with Bayer in revamp that reshapes diabetes, spotlights China

13th September 2018 Uncategorised 0

You might have witnessed some asset swaps in the biopharma industry. But what about executive swaps? Now, Sanofi is exchanging top executives with Bayer as it pushes ahead with a restructuring plan that consolidates the diabetes and cardiovascular market and highlights China.

More: Sanofi swaps executives with Bayer in revamp that reshapes diabetes, spotlights China
Source: fierce